Navigation Links
In Globalizing Biotech, Midwest Must Differentiate From Pack

CHICAGO In a column I wrote last year, I alluded to the internationalization of biotechnology. I was wrong. This business has become global. In fact, there are now 4,284 biotech companies in 25 countries, according to a May 2004 article in BioPharm International.

Moreover:

The biotech industry has 622 publicly traded companies around the world.

The industry spent $......

Full article >>> tific research that begins at universities. There are still some driving forces that will allow the U.S. to maintain an edge in this industry. They are:

1. The largest pharmaceutical drug market (about 50 percent of the world market),

2. The largest conglomeration of venture capital ($2.8 billion raised for biotech in 2003, which ties for the best year in VC funding of biotech)......

Full article >>> weather the storms of going public), one sees the following trend around the world:



The governments of other countries realize the importance of this industry, and while not able to match the U.S. in funding the industry, they have been creative in stimulating the growth of their local biotech industry. Even the conservative Japanese (which have traditionally not embraced biote......

Full article >>> except its held every year). This years attendance is expected to approach 20,000 people from all over the world.

The exhibit area for this event is like walking through Epcot Center at Disney where you have all these countries and cultures represented from around the world (except that its all about biotechnology).

The Midwests presence at this event should prove much stronger......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 05/17/04


Related biology technology :

1. Midwest life science stocks kept sizzling in Q2
2. Midwest life science stocks sizzle in a tepid first quarter
3. A Midwest passage to India, Part II
4. Midwest offers non-stop flight to North Carolina research park
5. A Midwest life-science odyssey comes full circle
6. Midwest hotter for healthcare investments
7. A Midwest small-cap, life-science surprise package
8. 2006: A mixed blessing for Midwest life science companies
9. Midwest gaining stature in nanotech research
10. Midwest colleges strong contenders for NIH funds
11. Japan on the rebound: Implications for Midwest
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... and NEW YORK , Feb. ... Lumeon , a leading digital health company, and ... provider of telemedicine and remote patient monitoring, announce ... telemedicine reimbursements.  DN Telehealth maximizes ... in real-time, extending consultations beyond a physical clinical ...
(Date:2/23/2017)... ... 2017 , ... BellBrook Labs is formalizing a significant expansion ... biochemical analyses critical for Lead Discovery. The company’s Lead Discovery Services will ... inhibitor potency and selectivity, mechanism of action, and inhibitor residence times on drug ...
(Date:2/23/2017)... , Feb. 23, 2017  MIODx announced today ... two key immunotherapy technologies from the University of ... a method to monitor a patient for response ... and CTLA-4.  The second license extends the technology ... is likely to have an immune-related adverse event ...
(Date:2/23/2017)... , Feb. 23, 2017  Seattle,s upscale Capitol Hill ... a strange place for a head lice treatment salon to ... between a Tuscan restaurant and a French bistro on E ... perfect. "We aren,t just any old lice clinic, we pride ... feel comfortable, and release some of the stigma associated with ...
Breaking Biology Technology:
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
(Date:2/2/2017)... 2, 2017   TapImmune, Inc. (NASDAQ: ... specializing in the development of innovative peptide and ... cancer and metastatic disease, announced today it has ... of a second clinical lot of TPIV 200, ... alpha. The manufactured vaccine product will be used ...
(Date:1/30/2017)... --  Invitae Corporation (NYSE: NVTA ), ... announced that it will report its fourth quarter and ... Monday, February 13, 2017, and Invitae,s management team will ... Eastern / 1:45 p.m. Pacific. During ... results, guidance, and recent developments and will spend the ...
Breaking Biology News(10 mins):